Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Masakazu Nakamura, Akira Oshima, Yoko Fujimoto, Nami Maruyama, Taro Ishibashi, Karen R. ReevesVolume:
29
Year:
2007
Language:
english
Pages:
1057
DOI:
10.1016/j.clinthera.2007.06.012
File:
PDF, 244 KB
english, 2007